Tuesday, March 19, 2024
ISSN 2765-8767
  • Home
  • About Us
  • Contact us
  • Support Us
  • Home
  • About Us
  • Contact us
  • Support Us

U.S. scientists enroll nearly 40,000 patients in high-stakes, $1.2 billion study of long COVID

The National Institutes of Health is rolling out one of the largest studies in the world to understand long COVID in a high-stakes effort to find definitive answers about a multitude of seemingly unrelated and sometimes debilitating symptoms that have plagued patients and confounded physicians.

The $1.15 billion taxpayer-funded study, called Recover, aims to enroll nearly 40,000 people by the end of this year. It will follow those participants over four years, comparing people with Covid to those who’ve never had it, with the goal of identifying all the long-term symptoms and finding out how the virus is causing them. The Patient-Led Research Collaborative said there were more than 200 long Covid symptoms across 10 organ systems, according to a study published last year in The Lancet.

Source: NBC

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Why are health insurance premiums going up?

How do you envision death?

How do you envision death?

As society entered the era of modern medicine, people developed a new understanding of death. Artist John Downman portrays two star-crossed lovers meeting for the last time: Edwin and Emma. For these two lovers, death is a welcomed reprieve from a life of sadness and separation.

Read more

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do